🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Does abstinence from 🍸🍻 improve prognosis in patients with alcohol associated cirrhosis and portal HTN? Check out this great CGH 📑 by Benedikt Hofer with summary by Sarah Khan, MD ⬇️ aasld.org/liver-fellow-n… #livertwitter #GITwitter #FOAMed #MedEd

If you want to get more information on #Alcohol 🍺🍷🥃and related #LiverDisease 🔥🚨 you may want to take a look at this book: Springer Nature Benedikt Hofer #livertwitter 📕link.springer.com/book/10.1007/9…

🔥Platelet activation in #cirrhosis #livertwitter More pronounced #platelet activation measured by platelet count-independent flow cytometry➡️ ✅Less decompensation & longer survival 🚩Higher thrombosis risk 🩸Not related to bleeding 📕HEPATOLOGY Journal 📢bit.ly/3O4imib

#LiverTwitter Benedikt Hofer MedUni Wien HEPATOLOGY Journal New findings shed light on the role of platelets in patients with cirrhosis meduniwien.ac.at/web/en/ueber-u…

"Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis" available to read 'open access' at bit.ly/4c3Tv8K #livertwitter #PBC #cirrhosis

@bavenocoop study published in Journal of Hepatology 📕t.ly/w6WM8 right before EASLnews congress 2024 #PortalPressure #HVPG predicts #decompensation in #MASLD #MASH cirrhosis #HVPG_10 #CSPH and #HVPG_16 indicate a stepwise increase in #liver-related events death

Cirrhosis Recompensation, one of the most interesting concepts in recent Hepatology, and a goal to achieve in our patients with decompensated cirrhosis, nicely explained by @ReibergerThomasa at #EASLCongress #LiverTwitter #WeShareEASL

#LiverTwitter Reticulated platelets #PLT in #Cirrhosis ? Just a surrogate for thrombocytopenia sciencedirect.com/science/articl… @DigestiveLiverDisease

HEPEX Lab for #LiverFibrosis and #PortalHypertension MedUni Wien @t_sorz Digital Histomorphometry & AI @KathiBonitz Macrophage scSeq Benedikt Hofer ALD recompensation Vlad Țâru Inflammasome #ACLF Oleksandr Petrenko | opetrenko.bsky.social omics #PSC #ECMatrix

How much 🍻Alcohol is in #MASLD? important to know sind it does make difference! 📕t.ly/RdHD- but #PortalHypertension remains a key driver of #liver #Events 📕t.ly/GUx2Q Reply 📨 t.ly/BQetE by @wilcokwanten Benedikt Hofer Sven Francque

🚨 #livertwitter Benedikt Hofer of Vienna Liver News MedUni Wien published a study on #Etiology-specific #Inflammation Patterns in 🏥patients and 🐭 models of #LiverDisease 📕Full Article in #Digestive #Liver #Disease 🔗t.ly/b_bkz

🧠Register for the #EASLJC to join authors Thomas Reiberger Benedikt Hofer & Wilhelmus Kwanten as they present & discuss their study investigating the prognostic role of HVPG in #MASLD-related #cACLD ✍️Register here: easl-eu.zoom.us/webinar/regist… 📰Read the article:

Missed the #EASLJC? 😳 Don't worry it's now available on demand! 👉easlcampus.eu/webinars/easl-… EASLnews #LiverTwitter #MASLD

📌In our November issue Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD #OpenAccess here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter Thomas Reiberger Sven Francque Wilco Kwanten Benedikt Hofer The Baveno Cooperation: an EASL Consortium

Dr. Benedikt Hofer of MedUni Wien showed in UEGJ that 🔥inflammation remains a 🔁dynamic component of #PortalHypertension in 🍻alcohol-related cirrhosis and ↘️regressive🕸️fibrosis models 🔗tinyurl.com/4pxw73jr

#twitterliver #PortalHypertension WP1 focuses on the classical & alternative renin-angiotensin system as a disease-driving mechanism in patients with compensated advanced chronic liver disease & investigates potentially beneficial effects of telmisartan in this patient group.⬇️⬇️

"#twitterliver 👋#PortalHypertension Fans !! MOTION WP 1 - Focusing on pathophysiological mechanisms in compensated Patients with liver cirrhosis.... 🌐More info in the video below 🔽🔽

Dr. Benedikt Hofer in UEGJ 🔥 Inflammation remains a dynamic component of portal hypertension #PH in regressive cirrhosis 🔗onlinelibrary.wiley.com/doi/10.1002/ue…

Our study with Benedikt Hofer MedUni Wien on “Aetiology-specific inflammation patterns in patients and animal models of cirrhosis" received quite some attention - another Editorial: sciencedirect.com/science/articl…

Vienna Liver News MedUni Wien EASLnews Congress #2025 in #Amsterdam